Document Detail


Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome.
MedLine Citation:
PMID:  14582073     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The authors report a case of adult-onset minimal change nephrotic syndrome (MCNS) that was resistant to steroid and cyclophosphamide therapy. Introduction of cyclosporin induced an usual cutaneous reaction of severe flushing attacks. Tacrolimus successfully alleviated both the nephrotic syndrome and the cutaneous side effect associated with cyclosporin use. The antiproteinuric mechanisms of tacrolimus and its potential in treating refractory MCNS and other forms of primary glomerulonephritides are discussed.
Authors:
Sydney Tang; Anthony W C Tang; Man Kei Tam; Yiu Wing Ho
Related Documents :
20729743 - Primary sclerosing cholangitis complicated by amyloid a amyloidosis: complete regressio...
7923963 - Combined treatment with cyclophosphamide and prednisolone can induce remission of nephr...
9499193 - Hemolytic uremic syndrome in prostatic carcinoma.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  American journal of kidney diseases : the official journal of the National Kidney Foundation     Volume:  42     ISSN:  1523-6838     ISO Abbreviation:  Am. J. Kidney Dis.     Publication Date:  2003 Nov 
Date Detail:
Created Date:  2003-10-28     Completed Date:  2004-04-09     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8110075     Medline TA:  Am J Kidney Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  E13-5     Citation Subset:  IM    
Affiliation:
Division of Nephrology, Department of Medicine and Geriatrics, United Christian Hospital, Kwun Tong, Hong Kong. scwtang@hkucc.hku.hk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Inflammatory Agents / therapeutic use
Cyclophosphamide / therapeutic use
Cyclosporine / adverse effects
Drug Eruptions / etiology
Drug Resistance
Female
Flushing / chemically induced
Humans
Immunosuppressive Agents / adverse effects,  therapeutic use*
Middle Aged
Nephrosis, Lipoid / drug therapy*
Prednisolone / therapeutic use
Remission Induction
Steroids / therapeutic use
Tacrolimus / therapeutic use*
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Immunosuppressive Agents; 0/Steroids; 109581-93-3/Tacrolimus; 50-18-0/Cyclophosphamide; 50-24-8/Prednisolone; 59865-13-3/Cyclosporine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Renal tubular regeneration by bone marrow-derived cells in a girl after bone marrow transplantation.
Next Document:  Severe acidosis caused by starvation and stress.